21 February 2024 in Genij Ortopedii
Background Ceramic materials are currently in wide demand in various fields of medicine. Zirconium ceramics demonstrate exceptional mechanical properties and biocompatibility and do not cause cytotoxic effects or allergic reactions in surrounding tissues.The objective was to present an analysis of current literature data on the use of zirconium ceramics as a bone replacement material in traumatology and orthopaedics.Materials and methods The search for publications was conducted using the databases of Scopus, PubMed and the electronic scientific library eLIBRARY in the Russian and English languages using the keywords: bioceramics, bone, bone defect, zirconate, zirconium ceramics, bone tissue engineering, implant, scaffold, augment, biointegration, bioactivity. Depth of search for scientific papers was from 2000 to 2023.Results and discussion Zirconium dioxide is the main ceramic bioinert material. The study presents the characteristics of ZrO2 as a bone replacement material and its comparison with titanium implants. Data are presented on various strategies for improving zirconium bioceramics: improving the surface of the material by physical and chemical methods, obtaining volumetric porosity, including using additive technologies, creating composite materials, and developing bioactive coatings. New methods of creating zirconium ceramics compatible with living tissues containing bioactive ions that promote both osseointegration and bone tissue regeneration have been actively studied.Conclusions Zirconium dioxide ceramics appear to be a promising alternative to titanium implants in terms of mechanical strength, biological functionality, chemical stability, osseointegration, and antibacterial properties. Future experimental and clinical studies will further improve zirconium ceramics.
3 March 2025 in Ural Medical Journal
Introduction. In developed countries, there is a trend towards a decrease in the prevalence of H. Pylori associated gastritis, which leads to an increase in the relative frequency of chronic autoimmune gastritis in the structure of gastric lesions in biopsy material. The observed trends, as well as the presumed underdiagnosis of autoimmune gastritis in the Russian Federation make it relevant to discuss the principles of diagnostics of this disease.Objective. Provide current data on the criteria for morphological diagnosis of chronic autoimmune gastritis.Materials and methods. Data on the problem were searched in the databases of scientific publications PubMed, Web of Science, Scopus, eLibrary.ru. The depth of the scientific search was 175 years (1849–2024).Results and discussion. The diagnosis of autoimmune gastritis is reduced to endoscopic examination with biopsy sampling according to the OLGA/Modified Sydney System diagnostic protocol (antral, incisura anglularis and body of the stomach). At the same time serological methods (detection of specific antibodies) do not always allow to confirm or refute the diagnosis, due to the existence of seronegative variant of the disease, which determines the primary role of morphological examination. The publication discusses the differential diagnosis of different stages of autoimmune gastritis with other types of chronic gastritis.Conclusion. Chronic autoimmune gastritis is a diagnosis that involves a gastroenterologist, endoscopist, and pathologist. The leading role of morphological methods in the diagnosis of chronic autoimmune gastritis is determined and substantiated.
23 April 2026 in Genij Ortopedii
Introduction The use of ceramic materials is a promising approach to bone defect repair. Various orthobiological agents are used to improve their properties and enhance their regenerative potential. The aim of this study was to determine the efficacy of platelet-rich plasma in repairing bone defects with yttria-doped zirconia ceramic implants. Materials and Methods Bioceramic samples were zirconium dioxide. The ceramic implants measured 0.15 × 0.15 × 1.00 cm. Male Chinchilla rabbits were used in the experiment: Group 1 ( n = 10) included animals that underwent bilateral metaphyseal bone defect filling with implantation of ceramic augments; Group 2 ( n = 10) included animals that underwent bone defect repair without implantation. Platelet-rich plasma (PRP) was injected into the bone defect in the right femur of rabbits in both groups; PRP was not injected into the defect in the left femur. Blood samples were collected preoperatively and at the end of the experiment, four and eight weeks after surgery. Key blood parameters, including C-reactive protein, and platelet-derived growth factor (PDGF) in PRP were determined. To assess the effect of PRP on the dynamics of osteogenesis, a comparative histological analysis of the tissue structure in the simulated bone defect area was conducted. Results No significant differences were found between the groups in key parameters of leukocytes, erythrocytes, and platelets, or C-reactive protein levels, either preoperatively or eight weeks after surgery. The concentration of PDGF in the injected PRP did not differ significantly between the groups. Histological analysis showed that injection of PRP increased the number of regenerating bone trabeculae and reduced the number and size of fibrotic foci and osteochondral callus in both groups. Discussion Autologous PRP has previously been shown to be a simple and effective way to enhance bone regeneration due to the release of multiple growth factors by platelets, which regulate key biological processes, including angiogenesis, inflammation resolution, and tissue regeneration. Our study aimed to investigate whether platelet-rich plasma enhances the osteogenic potential of zirconia ceramic implants in bone defect repair. Our results confirm that PRP, with a platelet concentration of 800 × 10 9 /L to 1200 × 10 9 /L, a white blood cell count of 4–7 %, and a red blood cell count of no more than 1 % of the baseline blood count, may be a useful tool for bone regeneration. Conclusion The use of PRP is effective in compensating bone defects using zirconia ceramic implants. However, further rigorous clinical studies are needed to integrate PRP-based methods into evidence-based medical practice.